Fever-tree, the premium mixer company, has reported a strong performance for the first half of 2024, with CEO Tim Warrillow announcing nearly
Innate Pharma (Euronext Paris: IPH) has reported encouraging advancements in its proprietary drug candidates, particularly lacutamab for T-cell lymphoma, during its First-Half
Streamline Health Solutions (NASDAQ: STRM), a provider of solutions for healthcare revenue cycle management, reported its second quarter financial results for the
By Ernest Scheyder (Reuters) – Native American opposition to Rio Tinto (NYSE:RIO) and BHP’s Resolution Copper mine could prove crucial for the 2024
In the Lovesac Second Quarter Fiscal 2025 Earnings Call, CEO Shawn Nelson detailed the company’s performance, which included a slight increase in
(Reuters) – U.S. railroad Union Pacific (NYSE:UNP) said on Thursday that all of its rail lines impacted by hurricane Francine
(Reuters) – U.S. household wealth rose last quarter to $163.8 trillion, a fresh record, driven by gains in real estate values as
By Moira Warburton WASHINGTON (Reuters) – A senior U.S. House Republican said on Thursday that his party needs to begin talks with Democrats
FRANKFURT (Reuters) – European Central Bank policymakers see an interest rate cut in October as unlikely, barring a major deterioration in the
By Philip Blenkinsop BRUSSELS (Reuters) -The European Commission said on Thursday it had received offers from electric vehicle makers in China for minimum
